Gilead Submits New Drug Application With FDA For Remdesivir
PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined
Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease
Biogen Spikes 10% On FDA Fast Review For Potential Alzheimer Treatment
UPDATED: FDA hands out a quick OK for potential SMA blockbuster risdiplam, giving Genentech and Roche a chance to challenge rivals on the price
IoT and data science will boost foodtech in the post-pandemic era
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir
Needham: Time to Turn Bullish on These 2 Stocks
FDA takes the lead on defining essential under Trump's 'Buy American' executive order — as industry warns of supply chain disruption
Beware harm to federal health agencies
Top 200 Medicines Annual Report: Climbing Mount Humira
3 "Strong Buy" Healthcare Stocks Under $5 That Could See Outsized Gains
Lundbeck gets cold feet, axes schizophrenia drug trial
3 Healthcare Stocks Under $5 That Could See Outsized Gains
New approach to airborne disinfection uses food-coloring dyes
Amarin: Improving HCP Access Should Drive More Vascepa Sales, Says Analyst
Decentralised trials – aided by tech – could boost clinical research
FDA clears Roche Epstein-Barr virus test for transplant patients
Pfizer, BioNTech Ink Deal To Supply Canada With Potential Covid-19 Vaccine
Sight Diagnostics raises $71M Series D for its blood analyzer
FDA touts advanced manufacturing to address Covid-19 shortfalls
Novavax Pops 15% On ‘Positive’ Early Trial Data From Covid-19 Candidate
Australia Approves Co-Diagnostics' Covid-19 Test; Stock Falls On Profit-Taking
CytoDyn Scores Safety Thumbs Up For Late-Stage Covid-19 Trial
DBV craters on FDA’s peanut allergy immunotherapy rejection
National Cancer Institute designates Penn’s Abramson Cancer Center as ‘exceptional’
Regeneron: Covid-19 Antibody Combo Prevents & Treats Disease In Animals
Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients
FDA Expands List Of Dangerous Hand Sanitizers To Over 100
Rival drugmakers launch joint trial of medicines for COVID-19